See analyst estimates and all valuation multiples for Health & Beauty
| Company | EV | EV/LTM Revenue | EV/LTM EBITDA |
|---|---|---|---|
| $453B | 7.4x | 17.4x | |
| $396B | 4.6x | 16.7x | |
| $253B | 4.8x | 20.1x | |
| $184B | 2.7x | 12.3x | |
| $92.8B | 1.7x | 8.2x | |
| $83.5B | 4.1x | 17.0x | |
| $67.1B | 3.4x | 12.5x | |
| $62.8B | 8.8x | 38.3x | |
| $59.4B | 3.9x | 15.6x | |
| $48.2B | 9.0x | 39.0x | |
| $44.4B | 3.0x | 20.8x | |
| $43.5B | 2.9x | 13.0x | |
| $41.8B | 4.3x | 17.6x | |
| $38.9B | 1.6x | 8.7x | |
| $32.7B | 2.7x | 17.9x | |
| $25.9B | 4.2x | 18.4x | |
| $24.8B | 2.1x | 12.1x | |
| $24.4B | 1.6x | 8.5x | |
| $22.0B | 2.1x | 6.0x | |
| $18.4B | 1.7x | 11.3x | |
| $13.8B | 8.2x | 39.7x | |
| $12.9B | 2.1x | 14.5x | |
| $12.5B | 2.1x | 10.3x | |
| $10.9B | 7.7x | 43.1x | |
| $10.0B | 6.5x | 26.0x | |
| $9.9B | 6.8x | 36.4x | |
| $8.7B | 1.4x | 8.2x | |
| $8.4B | 1.4x | 13.2x | |
| $7.2B | 7.3x | 28.3x | |
| $6.5B | 2.3x | 14.9x | |
| $6.4B | 9.5x | 29.8x | |
| $5.3B | 3.5x | 17.4x | |
| $5.2B | 1.2x | 7.2x | |
| $5.2B | 0.9x | 5.0x | |
| $5.1B | 2.4x | 13.7x | |
| $4.8B | 11.4x | 34.6x | |
| $4.5B | 1.5x | 6.6x | |
| $4.3B | 1.3x | 7.3x | |
| $4.2B | 8.6x | 33.5x | |
| $4.1B | 3.7x | 11.3x | |
| $4.1B | 1.3x | 8.0x | |
| $3.8B | 2.3x | 12.7x | |
| $3.5B | 1.7x | 10.1x | |
| $3.4B | 0.7x | 6.3x | |
| $3.4B | 3.9x | 9.6x | |
| $3.3B | 2.2x | 10.9x | |
| $3.3B | 2.7x | 16.6x | |
| $3.1B | 0.9x | 5.9x | |
| $3.1B | 9.3x | 34.7x | |
| $3.0B | 1.4x | 9.7x | |
| $2.8B | 1.1x | 5.8x | |
| $2.7B | 1.0x | 7.9x | |
| $2.6B | 2.5x | 11.1x | |
| $2.5B | 3.2x | 22.7x | |
| $2.3B | 0.5x | 6.7x | |
| $2.3B | 5.4x | 20.4x | |
| $2.3B | 1.0x | 7.7x | |
| $2.2B | 5.8x | 16.7x | |
| $2.1B | 3.7x | 18.1x | |
| $2.0B | 1.2x | 10.5x | |
| $2.0B | 1.8x | 12.7x | |
| $2.0B | 2.8x | 13.3x | |
| $1.8B | 1.0x | 7.6x | |
| $1.8B | 2.4x | 11.9x | |
| $1.7B | 6.5x | 18.3x | |
| $1.7B | 0.8x | 8.9x | |
| $1.7B | n/a | n/a | |
| $1.6B | 2.0x | 10.1x | |
| $1.6B | 1.2x | 8.5x | |
| $1.4B | 1.7x | 7.3x | |
| $1.3B | 0.6x | 5.9x | |
| $1.3B | 0.7x | 6.2x | |
| $1.2B | 1.6x | 10.8x | |
| $1.1B | 0.3x | 2.4x | |
| $1.0B | 2.5x | 11.3x | |
| $1.0B | 0.9x | 8.3x | |
| $1.0B | 2.2x | 10.5x | |
| $1.0B | 4.0x | 58.2x | |
| $981M | 7.7x | 29.1x | |
| $971M | 1.2x | 6.6x | |
| $804M | 1.9x | 11.3x | |
| $749M | n/a | n/a | |
| $682M | n/a | n/a | |
| $652M | n/a | n/a | |
| $635M | 0.9x | 7.1x | |
| $579M | 3.3x | 13.2x | |
| $536M | 0.8x | 3.6x | |
| $534M | 0.4x | n/a | |
| $507M | n/a | n/a | |
| $409M | 1.5x | 18.6x | |
| $390M | 1.3x | -18.5x | |
| $388M | n/a | n/a | |
| $318M | 1.5x | -33.8x | |
| $315M | 6.1x | 23.4x | |
| $314M | n/a | n/a | |
| $300M | n/a | n/a | |
| $295M | 1.0x | 7.9x | |
| $250M | 0.6x | 6.9x | |
| $237M | 1.6x | 7.1x | |
| $208M | n/a | n/a | |
| $197M | 1.0x | 9.7x | |
| $197M | 0.4x | 11.3x | |
| $185M | 0.5x | 8.4x | |
| $178M | 0.8x | 3.7x | |
| $177M | 2.1x | 12.5x | |
| $168M | 0.9x | 6.0x | |
| $147M | 2.3x | 8.3x | |
| $134M | 0.5x | 6.1x | |
| $123M | 0.5x | 5.0x | |
| $118M | n/a | n/a | |
| $87.1M | n/a | n/a | |
| $73.2M | n/a | n/a | |
| $71.3M | 0.3x | 7.4x | |
| $61.7M | 2.3x | 9.8x | |
| $42.2M | n/a | n/a | |
| $40.6M | n/a | n/a | |
| $40.5M | n/a | n/a | |
| $40.3M | 0.8x | n/a | |
| $28.0M | 2.2x | n/a | |
| $26.2M | n/a | n/a | |
| $20.8M | 1.1x | -12.0x | |
| $20.3M | n/a | n/a | |
| $19.2M | n/a | n/a | |
| $15.1M | n/a | n/a | |
| $9.0M | n/a | n/a | |
| $6.9M | n/a | n/a | |
| $5.1M | n/a | n/a | |
| $1.0M | n/a | n/a | |
| -$42.0M | -0.1x | -70.0x |
Valuation multiples as of last 12 months (LTM). Financial data powered by Morningstar, Inc.
See analyst estimates and M&A multiples for Health & Beauty